Medical Science News

RSS

Don and Karen Cohn's $2.5 million gift supports UC San Diego Health neurosurgery program

Don and Karen Cohn have given $2.5 million to create the Don and Karen Cohn Chancellor's Endowed Chair in Neurosurgery at University of California San Diego School of Medicine.

4 Sep 2021

Researchers develop statistical model to characterize how ketamine anesthesia affects the brain

By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.

4 Sep 2021

NIH awards $18.15 million to seven projects focused on interoception

The National Institutes of Health is awarding seven projects a total of $18.15 million over five years to a new effort focused on interoception—the ways in which organisms sense and regulate signals within their bodies.

4 Sep 2021

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

3 Sep 2021

Impact of colloidal aggregation in COVID-19 drug repurposing screens

A recent study investigated the influence of colloidal aggregation on early drug development in repurposing screens

3 Sep 2021

Higher daily step count reduces mortality in middle-aged adults

Study shows that daily steps are associated with mortality from coronary artery disease in young adults.

3 Sep 2021

Income, race, and ethnical-mediated inequities in COVID-19 vaccination across major US cities

Differences in vaccination rates across the 9 biggest US cities associated with race, ethnicity, and income levels.

3 Sep 2021

JunD promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA

Oncotarget published "JunD accentuates arecoline-induced disruption of tight junctions and promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA" which reported that the effects of low and high concentrations of arecoline on the stability of tight junctions and EMT induction were studied.

3 Sep 2021

Can COVID-19 vaccines affect athletic performance in the short term?

Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.

3 Sep 2021

Modeling study shows importance of contact tracing in preventing COVID-19 transmission

In the face of rising vaccination rates, untraced cases may increase the number of COVID-19 cases. A new study led by Choo-Yee Ting from Multimedia University in Malaysia found that contact tracing remains an important tool in mitigating coronavirus spread and subsequent infection.

3 Sep 2021

Scientists identify novel mechanism that links genetic defect in IBD patients to gut leakiness

A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how intestinal epithelial cells maintain a barrier.

3 Sep 2021

Precursor to ulcerative colitis exists several years before disease onset, study shows

After the first symptoms, the diagnosis of the bowel disease ulcerative colitis may take a few months. As shown in a study at örebro University, there is, however, a precursor to the disease already several years before its onset.

3 Sep 2021

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

A new preprint investigates the efficacy of a booster vaccine on a nationwide scale in reducing viral spread and the number of severe COVID-19 cases.

3 Sep 2021

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

A new study reports long-lasting, effective protection against severe disease with the AZD7442 antibody cocktail.

3 Sep 2021

UVA research quantifies the antibody response generated by Pfizer and Moderna COVID vaccines

New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna COVID vaccines.

3 Sep 2021

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases (NCID) and Singapore General Hospital (SGH), have discovered a simple and rapid method to measure the T-cell immune response to the SARS-CoV-2 virus, which causes COVID-19.

3 Sep 2021

Research reveals the effects of acute isolation on vocal and non-vocal social behaviors in mice

Female mice exhibit a strong drive to socialize with other females following periods of acute isolation, significantly increasing their production of social calls that are akin to human emotional vocalizations, new Cornell University research finds.

2 Sep 2021

Study establishes a new resource for exploring and understanding Alzheimer's disease

A study led by researchers from Brigham and Women's Hospital has established a new resource for exploring and understanding Alzheimer's disease (AD) on an individualized level.

2 Sep 2021

Link discovered between brain’s opioid system and food craving triggered by external stimuli

Brain regulation of feeding behavior traits has remained incompletely understood. In their latest study, researchers at the Turku PET Centre, Finland, discovered a connection between the function of the opioid system and food craving triggered by appetitive external stimuli.

2 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

Medical Science News

Don and Karen Cohn's $2.5 million gift supports UC San Diego Health neurosurgery program

Researchers develop statistical model to characterize how ketamine anesthesia affects the brain

NIH awards $18.15 million to seven projects focused on interoception

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

Impact of colloidal aggregation in COVID-19 drug repurposing screens

Higher daily step count reduces mortality in middle-aged adults

Income, race, and ethnical-mediated inequities in COVID-19 vaccination across major US cities

JunD promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA

Can COVID-19 vaccines affect athletic performance in the short term?

Modeling study shows importance of contact tracing in preventing COVID-19 transmission

Scientists identify novel mechanism that links genetic defect in IBD patients to gut leakiness

Precursor to ulcerative colitis exists several years before disease onset, study shows

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

UVA research quantifies the antibody response generated by Pfizer and Moderna COVID vaccines

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

Research reveals the effects of acute isolation on vocal and non-vocal social behaviors in mice

Study establishes a new resource for exploring and understanding Alzheimer's disease

Link discovered between brain’s opioid system and food craving triggered by external stimuli

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News